Komori
Governance9265YAMASHITA HEALTH CARE HOLDINGS,INC.Trading & Wholesale

Overview of the Results of the Evaluation of the Board of Directors’ Effectiveness

The Company conducted a self-assessment of the Board of Directors' effectiveness and identified enhancing discussions on medium- to long-term strategy, as well as optimizing the timing and volume of materials distributed and the number of agenda items, as areas for improvement. It will proceed with earlier distribution of materials, advance briefing sessions, and a review of the criteria for submitting matters to the Board and the delegation of authority.

Worth reading
83Important
Scored from 2 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directors8 in total (outside directors: Not disclosed)
Changes this time

The Company conducted an evaluation of the Board of Directors' effectiveness and identified enhancing discussions on medium- to long-term strategy, as well as optimizing the timing and volume of materials distributed and the number of agenda items, as areas for improvement. It will proceed with earlier distribution of materials, advance briefing sessions, and a review of the criteria for submitting matters to the Board and the delegation of authority.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directors8 in total (outside directors: Not disclosed)
Changes this timeThe Company conducted an evaluation of the Board of Directors' effectiveness and identified enhancing discussions on medium- to long-term strategy, as well as optimizing the timing and volume of materials distributed and the number of agenda items, as areas for improvement. It will proceed with earlier distribution of materials, advance briefing sessions, and a review of the criteria for submitting matters to the Board and the delegation of authority.
Items this document does not state (5)
Number of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company recognized the need to improve Board operations, including optimizing the timing and volume of materials distributed and the number of agenda items, so that directors can secure sufficient time for review, as enhancing discussions on medium- to long-term strategy remains an issue.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Overview of the Results of the Evaluation of the Board of Directors’ Effectiveness | YAMASHITA HEALTH CARE HOLDINGS,INC. (9265) timely disclosure | Komori